Imran K. Tailor

Riyadh, Saudi Arabia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Guidelines on Management of Multiple Myeloma in the Relapsed/Refractory Setting: The Saudi Myeloma Working Group Guideline.

Guidelines on Management of Multiple Myeloma in the Relapsed/Refractory Setting: The Saudi Myeloma Working Group Guideline.

Journal: Clinical lymphoma, myeloma & leukemia

Published: February 25, 2025

Definition, Diagnosis, Risk Stratification and Management of Newly Diagnosed Multiple Myeloma: The Saudi Myeloma Working Group Guidelines.

Definition, Diagnosis, Risk Stratification and Management of Newly Diagnosed Multiple Myeloma: The Saudi Myeloma Working Group Guidelines.

Journal: Clinical lymphoma, myeloma & leukemia

Published: February 21, 2025

Advancing the understanding of venetoclax in t(11;14)-positive multiple myeloma: a comprehensive review of clinical evidence and future prospects.

Advancing the understanding of venetoclax in t(11;14)-positive multiple myeloma: a comprehensive review of clinical evidence and future prospects.

Journal: Hematology (Amsterdam, Netherlands)

Published: December 27, 2023

De novo lymphoid blastic phase chronic myeloid leukemia: report and contemporary discussion.

De novo lymphoid blastic phase chronic myeloid leukemia: report and contemporary discussion.

Journal: Hematology (Amsterdam, Netherlands)

Published: November 30, 2022

Efficacy and Safety of Azacytidine in Combination With Fludarabine and High-Dose Cytarabine With G-CSF (FLAG) in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study.

Efficacy and Safety of Azacytidine in Combination With Fludarabine and High-Dose Cytarabine With G-CSF (FLAG) in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study.

Journal: Clinical lymphoma, myeloma & leukemia

Published: May 11, 2021

Clinical course and outcomes of COVID-19 in hematopoietic cell transplant patients, a regional report from the Middle East.

Clinical course and outcomes of COVID-19 in hematopoietic cell transplant patients, a regional report from the Middle East.

Journal: Bone marrow transplantation

Published: March 03, 2021

Use of Thrombopoietin Receptor Agonists in Pregnancy: A Review of the Literature.

Use of Thrombopoietin Receptor Agonists in Pregnancy: A Review of the Literature.

Journal: Hematology/oncology and stem cell therapy

Published: January 23, 2021

Role of 18F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography Imaging in the Prediction of Prognosis in Patients With Indolent Lymphoma: Prospective Study.

Role of 18F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography Imaging in the Prediction of Prognosis in Patients With Indolent Lymphoma: Prospective Study.

Journal: JMIR formative research

Published: October 10, 2020

Prolonged Survival of a Patient with Chronic Myeloid Leukemia in Accelerated Phase with Recurrent Isolated Central Nervous System Blast Crisis.

Prolonged Survival of a Patient with Chronic Myeloid Leukemia in Accelerated Phase with Recurrent Isolated Central Nervous System Blast Crisis.

Journal: The American journal of case reports

Published: September 13, 2020

Outcome of Myeloma Patients with COVID-19 on Active Lenalidomide-Based Therapy: Does Lenalidomide Protect From Severe COVID-19?

Outcome of Myeloma Patients with COVID-19 on Active Lenalidomide-Based Therapy: Does Lenalidomide Protect From Severe COVID-19?

Journal: Hematology/oncology and stem cell therapy

Published: July 26, 2020

The use of 5-azacytidine in pregnant patient with Acute Myeloid Leukemia (AML): a case report.

The use of 5-azacytidine in pregnant patient with Acute Myeloid Leukemia (AML): a case report.

Journal: BMC pregnancy and childbirth

Published: August 04, 2019

Systemic Lupus Erythematosus Presenting as Hematoma of the Hand Due to Acquired Inhibitors to Factor VIII: Early and Prolonged Remission Achieved with Upfront Rituximab.

Systemic Lupus Erythematosus Presenting as Hematoma of the Hand Due to Acquired Inhibitors to Factor VIII: Early and Prolonged Remission Achieved with Upfront Rituximab.

Journal: Cureus

Published: August 02, 2019

Showing 1-12 of 18

Last Updated: 09/26/2026